Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/23/2025

Reducing Risperidone Dose for Somnolence Management

Rationale for Dose Reduction

  • For elderly or frail patients, guidelines recommend using lower doses of risperidone and titrating gradually to minimize adverse effects 1, 2

Implementation Strategy

  • A gradual reduction approach is recommended, with monitoring for improvement in somnolence within 48-72 hours of dose reduction and for any re-emergence of symptoms that were previously controlled by the higher dose 1, 3

Important Considerations

  • Underlying conditions should be considered to ensure somnolence is not due to other causes such as metabolic disturbances, infection, or other medications 2

Potential Pitfalls

  • Symptom recurrence should be monitored, as re-emergence of symptoms that were previously controlled by the higher dose can occur 3
  • Individual variability in response to dose reduction should be considered, as some patients may require a dose between 0.125 mg and 0.375 mg for optimal balance between efficacy and side effects 2

Alternative Management Strategies

  • If somnolence persists despite dose reduction to 0.125 mg twice daily, consideration should be given to consulting with a specialist for alternative medication options or further management strategies 4